;){kind=link}
Mr. John Li
Address:
Fuyong, Shenzhen, Guangdong, China
Telephone:
Zip Code:
Fax:
| Please sign in to view contact details |
Account Registered in:
2024
Business Range:
Chemicals, Health & Medicine
Business Type:
Manufacturer/Factory
Company Introduction
Trade Capacity
Production Capacity
BLIJVEN, Based on five major technology platforms, We have developed several blockbuster peptide drugs such as semaglutide and liraglutide. At the same time, it has formed a complete product layout in medical beauty peptide medicines, antiviral peptide drugs and vaccines, medical beauty protein raw materials and ophthalmology.
In terms of medical beauty raw materials, we have cooperated with a ...
In terms of medical beauty raw materials, we have cooperated with a ...
BLIJVEN, Based on five major technology platforms, We have developed several blockbuster peptide drugs such as semaglutide and liraglutide. At the same time, it has formed a complete product layout in medical beauty peptide medicines, antiviral peptide drugs and vaccines, medical beauty protein raw materials and ophthalmology.
In terms of medical beauty raw materials, we have cooperated with a doctoral team from Shandong University of Technology to establish an exosome production and separation and purification workshop, and started to develop products using exosomes as raw materials. Animal experiments on related products are underway.
In term of generic drugs and new drug projects, including the development of targeted peptide (PDC) projects, benchmarking against ADC drugs, treating cancer, using AI technology to assist in new drug development, and transferring technology to large domestic and foreign pharmaceutical companies.
In terms of medical beauty raw materials, we have cooperated with a doctoral team from Shandong University of Technology to establish an exosome production and separation and purification workshop, and started to develop products using exosomes as raw materials. Animal experiments on related products are underway.
In term of generic drugs and new drug projects, including the development of targeted peptide (PDC) projects, benchmarking against ADC drugs, treating cancer, using AI technology to assist in new drug development, and transferring technology to large domestic and foreign pharmaceutical companies.
International Commercial Terms(Incoterms):
FOB, EXW, CFR, CIF
Terms of Payment:
LC, T/T
Number of Foreign Trading Staff:
1~3 People
Export Year:
2024-01-01
Export Percentage:
1%~10%
Main Markets:
North America, South America, Southeast Asia
Import & Export Mode:
Have Own Export License
Factory Address:
Fuyong, Shenzhen, Guangdong, China
R&D Capacity:
Own Brand()
No. of R&D Staff:
21-30 People
No. of Production Lines:
2
Annual Output Value:
US$2.5 Million - US$5 Million